<VariationArchive VariationID="2114831" VariationName="NM_000360.4(TH):c.739_743dup (p.Cys248fs)" VariationType="Duplication" Accession="VCV002114831" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2164834" VariationID="2114831">
      <GeneList>
        <Gene Symbol="TH" FullName="tyrosine hydroxylase" GeneID="7054" HGNC_ID="HGNC:11782" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p15.5</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="2163929" stop="2171815" display_start="2163929" display_stop="2171815" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="2185158" stop="2193034" display_start="2185158" display_stop="2193034" Strand="-" />
          </Location>
          <OMIM>191290</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000360.4(TH):c.739_743dup (p.Cys248fs)</Name>
      <CanonicalSPDI>NC_000011.10:2166984:CAGGC:CAGGCCAGGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11p15.5</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="2166984" stop="2166985" display_start="2166984" display_stop="2166985" variantLength="5" positionVCF="2166984" referenceAlleleVCF="G" alternateAlleleVCF="GCAGGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="2188214" stop="2188215" display_start="2188214" display_stop="2188215" variantLength="5" positionVCF="2188214" referenceAlleleVCF="G" alternateAlleleVCF="GCAGGC" />
      </Location>
      <ProteinChange>C248fs</ProteinChange>
      <ProteinChange>C275fs</ProteinChange>
      <ProteinChange>C279fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.2166985_2166989dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.2166985_2166989dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.2188215_2188219dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.2188215_2188219dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008128.1" sequenceAccession="NG_008128" sequenceVersion="1" change="g.9817_9821dup">
            <Expression>NG_008128.1:g.9817_9821dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000360.4" sequenceAccession="NM_000360" sequenceVersion="4" change="c.739_743dup" MANESelect="true">
            <Expression>NM_000360.4:c.739_743dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000351.2" sequenceAccession="NP_000351" sequenceVersion="2" change="p.Cys248fs">
            <Expression>NP_000351.2:p.Cys248fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_199292.3" sequenceAccession="NM_199292" sequenceVersion="3" change="c.832_836dup">
            <Expression>NM_199292.3:c.832_836dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_954986.2" sequenceAccession="NP_954986" sequenceVersion="2" change="p.Cys279fs">
            <Expression>NP_954986.2:p.Cys279fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_199293.3" sequenceAccession="NM_199293" sequenceVersion="3" change="c.820_824dup">
            <Expression>NM_199293.3:c.820_824dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_954987.2" sequenceAccession="NP_954987" sequenceVersion="2" change="p.Cys275fs">
            <Expression>NP_954987.2:p.Cys275fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000360.4(TH):c.739_743dup (p.Cys248fs) AND Autosomal recessive DOPA responsive dystonia" Accession="RCV003032358" Version="2">
        <ClassifiedConditionList TraitSetID="3340">
          <ClassifiedCondition DB="MedGen" ID="C2673535">Autosomal recessive DOPA responsive dystonia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-23" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22264700</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24753243</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3340" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5903" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive DOPA responsive dystonia</ElementValue>
                <XRef ID="715827001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tyrosine Hydroxylase-Deficient Dopa-Responsive Dystonia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Segawa syndrome, autosomal recessive</ElementValue>
                <XRef ID="Segawa+syndrome%2C+autosomal+recessive/6484" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYT-TH</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">TH-deficient dopa-responsive dystonia</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1902" />
                <XRef ID="1902" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Tyrosine hydroxylase (TH) deficiency is associated with a broad phenotypic spectrum. Based on severity of symptoms/signs as well as responsiveness to levodopa therapy, clinical phenotypes caused by pathogenic variants in TH are divided into (1) TH-deficient dopa-responsive dystonia (the mild form of TH deficiency), (2) TH-deficient infantile parkinsonism with motor delay (the severe form), and (3) TH-deficient progressive infantile encephalopathy (the very severe form). In individuals with TH-deficient dopa-responsive dystonia (DYT5b, DYT-TH), onset is between age 12 months and 12 years; initial symptoms are typically lower-limb dystonia and/or difficulty in walking. Diurnal fluctuation of symptoms (worsening of the symptoms toward the evening and their alleviation in the morning after sleep) may be present. In most individuals with TH-deficient infantile parkinsonism with motor delay, onset is between age three and 12 months. In contrast to TH-deficient DRD, motor milestones are overtly delayed in this severe form. Affected infants demonstrate truncal hypotonia and parkinsonian symptoms and signs (hypokinesia, rigidity of extremities, and/or tremor). In individuals with TH-deficient progressive infantile encephalopathy, onset is before age three to six months. Fetal distress is reported in most. Affected individuals have marked delay in motor development, truncal hypotonia, severe hypokinesia, limb hypertonia (rigidity and/or spasticity), hyperreflexia, oculogyric crises, ptosis, intellectual disability, and paroxysmal periods of lethargy (with increased sweating and drooling) alternating with irritability.</Attribute>
                <XRef ID="NBK1437" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301610</ID>
                <ID Source="BookShelf">NBK1437</ID>
              </Citation>
              <XRef ID="101150" DB="Orphanet" />
              <XRef ID="C2673535" DB="MedGen" />
              <XRef ID="MONDO:0011551" DB="MONDO" />
              <XRef Type="MIM" ID="605407" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="6021265" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16195645|MedGen:C1854299" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003336914" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22264700</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24753243</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with TH-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Cys279Trpfs*34) in the TH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TH are known to be pathogenic (PMID: 22264700, 24753243).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.2188214_2188215insCAGGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1854299" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="6021265" TraitType="Disease" MappingType="XRef" MappingValue="C1854299" MappingRef="MedGen">
        <MedGen CUI="C2673535" Name="Autosomal recessive DOPA responsive dystonia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

